What is the treatment for contact dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Contact Dermatitis

The most effective treatment for contact dermatitis requires identifying and completely avoiding the causative agent, applying mid-to-high potency topical corticosteroids for inflammation control, and using emollients liberally to repair the skin barrier. 1

Initial Management Approach

The cornerstone of treatment is three-pronged: allergen/irritant identification and avoidance, topical corticosteroid therapy, and aggressive moisturization. 1 This approach applies to both irritant and allergic contact dermatitis, though the specific interventions differ slightly.

Allergen and Irritant Identification

  • Obtain a detailed history focusing on initial symptom location, spread pattern, relationship to specific products or activities, and occupational/recreational exposures. 1
  • Pattern and morphology alone are unreliable for distinguishing between irritant, allergic, or endogenous dermatitis—patch testing is essential for persistent cases. 1
  • Refer for patch testing to at least an extended standard series of allergens when dermatitis persists despite treatment or the causative agent remains unknown. 1
  • Consider workplace visits if occupational exposure is suspected, as these are critical for identifying hidden allergens and assessing procedures causing accidental exposure. 1

Common pitfall: Do not apply potent topical steroids to the back within 2 days of patch testing, as this causes false negatives. 1 Avoid oral corticosteroids or immunosuppressants during testing; if unavoidable, keep prednisolone ≤10 mg daily. 1

Topical Corticosteroid Therapy

For Localized Acute Contact Dermatitis

  • Apply mid-to-high potency topical corticosteroids such as triamcinolone 0.1% or betamethasone valerate 0.1% to affected areas. 1, 2
  • For persistent dermatitis failing initial therapy, escalate to very high potency corticosteroids such as clobetasol propionate 0.05% for 2 weeks. 1
  • Very high potency steroids achieve clear or almost clear skin in 67.2% of patients with severe dermatitis over 2 weeks, with low adverse event rates (0.8% withdrawals). 1

For Extensive Contact Dermatitis

  • When allergic contact dermatitis involves >20% body surface area, systemic steroid therapy is required and provides relief within 12-24 hours. 2
  • For severe rhus (poison ivy) dermatitis, taper oral prednisone over 2-3 weeks—rapid discontinuation causes rebound dermatitis. 2

Critical caveat: Exercise extreme caution with topical corticosteroids on facial skin, as prolonged use causes skin thinning, telangiectasia, perioral dermatitis, and red face syndrome due to increased percutaneous absorption. 1 Prolonged use on any site can cause steroid-induced damage to the skin barrier. 1

Important note: One experimental study found corticosteroids ineffective for surfactant-induced irritant dermatitis compared to vehicle, though this counterintuitive finding requires verification with other irritants. 3 However, clinical guidelines consistently support their use based on broader clinical experience. 1

Emollient and Moisturizer Therapy

  • Replace all soaps and detergents with emollients as soap substitutes—these are common irritants that perpetuate dermatitis. 1
  • Use moisturizers packaged in tubes rather than jars to prevent contamination. 1
  • Apply two fingertip units of moisturizer to hands after each washing. 1
  • Use the "soak and smear" technique for hands: soak in plain water for 20 minutes, then immediately apply moisturizer to damp skin nightly for up to 2 weeks. 1
  • Apply moisturizers liberally—recommended amount is 100g per 2 weeks for trunk area. 1
  • After-work creams have demonstrated benefit in reducing irritant contact dermatitis incidence and should be readily available in workplace settings. 1

Protective Measures

  • Use appropriate gloves based on specific exposures: rubber or PVC gloves with cotton liners for household tasks. 1
  • For latex allergy, use accelerator-free gloves such as rubber-free neoprene or nitrile gloves. 1
  • In occupational settings, select gloves based on specific chemical exposures and consider permeation time—"impervious" gloves have finite protection duration. 1
  • Remove gloves regularly to prevent sweat accumulation, which aggravates dermatitis. 1
  • Apply moisturizer before wearing gloves. 1

Important caveat: Barrier creams alone have questionable value in protecting against irritants and should not be over-promoted, as they may create false security and reduce implementation of appropriate preventive measures. 1

Critical Avoidance Measures

  • Do not wash hands with dish detergent or other known irritants. 1
  • Avoid very hot or very cold water for hand washing. 1
  • Do not use disinfectant wipes to clean hands. 1
  • Avoid products containing topical antibiotics without indication. 1
  • Avoid prolonged occlusion without underlying moisturizer application. 1

Second-Line Therapies for Refractory Cases

When first-line treatment fails:

  • Consider topical tacrolimus 0.1% where topical steroids are unsuitable, ineffective, or when chronic facial dermatitis raises concerns about steroid-induced skin damage. 1
  • Topical tacrolimus has shown effectiveness in nickel-induced allergic contact dermatitis and avoids the risk of corticosteroid allergy. 1
  • Offer alitretinoin for severe chronic hand eczema. 1
  • Phototherapy (PUVA) is an established second-line treatment for chronic contact dermatitis resistant to topical steroids, supported by prospective clinical trials. 1
  • For steroid-resistant chronic hand dermatitis, consider azathioprine or ciclosporin, both supported by prospective clinical trials. 1

Special Considerations for Facial Dermatitis

Facial dermatitis is the prototypical presentation of cosmetic contact dermatitis, with the eyelids frequently involved. 4 Common sources include shampoo, conditioner, facial cleansers, makeup remover, mascara, nail polish, acrylic nails, makeup sponges, eyelash curlers, and allergens transferred from hands. 4

  • Lateral facial/neck dermatitis often represents a "rinse-off" pattern from shampoo and/or conditioner. 4
  • Central facial dermatitis can be due to gold released from rings contaminating makeup foundation, or ingredients in moisturizers, wrinkle creams, topical medications, or makeup. 4
  • Generalized facial dermatitis should trigger consideration of airborne contactants, facial cleansers, makeup foundation, and moisturizers/medications applied confluently. 4

Prognosis and Long-Term Outlook

  • Prognosis for occupational contact dermatitis is often poor: only 25% of patients achieve complete healing, with 50% having periodic symptoms and 25% having permanent symptoms. 1
  • Changing occupation does not improve prognosis in 40% of cases. 1
  • Early identification and complete avoidance of allergens offers the best chance for resolution. 1
  • Complete resolution is expected if the causative agent is identified and avoided; chronic cases develop if triggers are not identified or eliminated. 1

Common Allergens to Consider

The most common substances causing contact dermatitis include poison ivy, nickel, and fragrances. 2 Recent years have identified 10 new contact allergens, several relating to anti-aging products. 5 Frequent allergens causing considerable morbidity include methylisothiazolinone (preservative), fragrance allergens (especially terpenes), and acrylates found in medical devices for diabetes control. 5

References

Guideline

Contact Dermatitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of contact dermatitis.

American family physician, 2010

Research

Efficacy of corticosteroids in acute experimental irritant contact dermatitis?

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2001

Research

Contact Dermatitis to Cosmetics.

Clinical reviews in allergy & immunology, 2019

Research

Novel insights into contact dermatitis.

The Journal of allergy and clinical immunology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.